CCL2 and amyotrophic lateral sclerosis: Conclusion: These results demonstrate that the CCL2‐CCR2 axis drives immune cell infiltration targeting NMJs in ALS and suggest that these immune pathways can be therapeutically modulated to protect NMJs from denervation.